CN1062605C - 大肠杆菌疫苗的制备方法 - Google Patents

大肠杆菌疫苗的制备方法 Download PDF

Info

Publication number
CN1062605C
CN1062605C CN90107108A CN90107108A CN1062605C CN 1062605 C CN1062605 C CN 1062605C CN 90107108 A CN90107108 A CN 90107108A CN 90107108 A CN90107108 A CN 90107108A CN 1062605 C CN1062605 C CN 1062605C
Authority
CN
China
Prior art keywords
toxin
coli
preparation
strains
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN90107108A
Other languages
English (en)
Chinese (zh)
Other versions
CN1049523A (zh
Inventor
约翰·富朗西斯科·凡·单·博石
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Akzo Nobel NV
Original Assignee
Akzo N
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo N filed Critical Akzo N
Publication of CN1049523A publication Critical patent/CN1049523A/zh
Application granted granted Critical
Publication of CN1062605C publication Critical patent/CN1062605C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN90107108A 1989-08-18 1990-08-18 大肠杆菌疫苗的制备方法 Expired - Lifetime CN1062605C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL89202110.6 1989-08-18
EP89202110 1989-08-18

Publications (2)

Publication Number Publication Date
CN1049523A CN1049523A (zh) 1991-02-27
CN1062605C true CN1062605C (zh) 2001-02-28

Family

ID=8202455

Family Applications (1)

Application Number Title Priority Date Filing Date
CN90107108A Expired - Lifetime CN1062605C (zh) 1989-08-18 1990-08-18 大肠杆菌疫苗的制备方法

Country Status (16)

Country Link
US (1) US5750115A (enExample)
EP (1) EP0413378B1 (enExample)
JP (1) JP3031561B2 (enExample)
KR (1) KR0177510B1 (enExample)
CN (1) CN1062605C (enExample)
AU (1) AU635062B2 (enExample)
CA (1) CA2022420C (enExample)
DE (1) DE69016129T2 (enExample)
DK (1) DK0413378T3 (enExample)
ES (1) ES2070266T3 (enExample)
GR (1) GR3015782T3 (enExample)
HU (2) HU210965B (enExample)
IL (1) IL95175A (enExample)
NZ (1) NZ234933A (enExample)
TW (1) TW204353B (enExample)
ZA (1) ZA906100B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0314224B1 (en) * 1987-10-26 1992-05-27 Akzo N.V. Vaccine against e.coli septicaemia in poultry
EP1011440A4 (en) * 1997-05-16 2003-08-06 Medical Defense Tech Llc VACCINE AGAINST THE CORE OF LIPOPOLYSACCHARIDES
US6749831B1 (en) * 1997-05-16 2004-06-15 Medical Defense Technology, Llc Vaccine against lipopolysaccharide core
BR9910438A (pt) * 1998-05-15 2001-01-02 Mkb Invest Ltd Partnership Composições e processos para imunização de aves domésticas
US8828226B2 (en) 2003-03-01 2014-09-09 The Trustees Of Boston University System for assessing the efficacy of stored red blood cells using microvascular networks
CN101273133A (zh) * 2005-08-30 2008-09-24 联邦科学工业研究组织 生物活性多肽的细菌传送
EP2355860B1 (en) 2009-10-12 2018-11-21 New Health Sciences, Inc. Blood storage bag system and depletion devices with oxygen and carbon dioxide depletion capabilities
BR112012008682A2 (pt) 2009-10-12 2017-06-20 New Health Sciences Inc "dispositivo de depleção de oxigênio, e, método para remover oxigênio de células vermelhas do sangue."
US11284616B2 (en) 2010-05-05 2022-03-29 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
US9199016B2 (en) 2009-10-12 2015-12-01 New Health Sciences, Inc. System for extended storage of red blood cells and methods of use
US12089589B2 (en) 2009-10-12 2024-09-17 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
EP4091645A1 (en) 2010-08-25 2022-11-23 Hemanext Inc. Method for enhancing red blood cell quality and survival during storage
PT3539381T (pt) 2010-11-05 2023-09-26 Hemanext Inc Irradiação de glóbulos vermelhos e armazenamento anaeróbico
US9067004B2 (en) 2011-03-28 2015-06-30 New Health Sciences, Inc. Method and system for removing oxygen and carbon dioxide during red cell blood processing using an inert carrier gas and manifold assembly
US8926980B2 (en) * 2011-07-11 2015-01-06 Camas Incorporated Compositions against bacterial toxins
ES2742949T3 (es) 2011-08-10 2020-02-17 New Health Sciences Inc Dispositivo integrado de filtrado para el agotamiento de leucocitos, oxígeno y/o co2 y separación de plasma
WO2014134503A1 (en) 2013-02-28 2014-09-04 New Health Sciences, Inc. Gas depletion and gas addition devices for blood treatment
CN107530377B (zh) 2015-03-10 2021-09-03 新健康科学股份有限公司 氧减少一次性套件、装置及其使用方法
CA2983295C (en) 2015-04-23 2024-02-13 New Health Sciences, Inc. Anaerobic blood storage containers
EP3297641B1 (en) 2015-05-18 2025-07-09 Hemanext Inc. Methods for the storage of whole blood, and compositions thereof
PT3463466T (pt) 2016-05-27 2022-04-04 Hemanext Inc Método de armazenamento de sangue anaeróbio e inativação de patógenos
US11260119B2 (en) 2018-08-24 2022-03-01 Pfizer Inc. Escherichia coli compositions and methods thereof
US12138302B2 (en) 2020-10-27 2024-11-12 Pfizer Inc. Escherichia coli compositions and methods thereof
US12357681B2 (en) 2020-12-23 2025-07-15 Pfizer Inc. E. coli FimH mutants and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58135819A (ja) * 1982-02-09 1983-08-12 Nisshin Flour Milling Co Ltd 鶏の大腸菌症の予防法
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4702911A (en) 1985-09-27 1987-10-27 Immunomed Corporation Preparation of bacterium pili subunits and vaccines containing pili subunits
US4886748A (en) * 1986-03-11 1989-12-12 Shionogi & Co., Ltd. DNA encoding flagellin and vector having the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF BACTEIOLOGY VOL.168 NO.3 1986.12.1 G KUWAJIMA等 *

Also Published As

Publication number Publication date
DE69016129T2 (de) 1995-05-24
CA2022420C (en) 2000-03-28
US5750115A (en) 1998-05-12
HUT59612A (en) 1992-06-29
DE69016129D1 (de) 1995-03-02
AU635062B2 (en) 1993-03-11
CA2022420A1 (en) 1991-02-19
TW204353B (enExample) 1993-04-21
EP0413378B1 (en) 1995-01-18
ES2070266T3 (es) 1995-06-01
CN1049523A (zh) 1991-02-27
EP0413378A1 (en) 1991-02-20
GR3015782T3 (en) 1995-07-31
HU211827A9 (en) 1995-12-28
IL95175A (en) 1994-05-30
IL95175A0 (en) 1991-06-10
AU6109990A (en) 1991-02-21
KR0177510B1 (ko) 1999-03-20
NZ234933A (en) 1992-06-25
DK0413378T3 (da) 1995-05-15
JPH03184996A (ja) 1991-08-12
HU905053D0 (en) 1991-01-28
JP3031561B2 (ja) 2000-04-10
HU210965B (en) 1995-09-28
KR910004209A (ko) 1991-03-28
ZA906100B (en) 1991-05-29

Similar Documents

Publication Publication Date Title
CN1062605C (zh) 大肠杆菌疫苗的制备方法
Ikemori et al. Passive protection of neonatal calves against bovine coronavirus-induced diarrhea by administration of egg yolk or colostrum antibody powder
ES2603531T3 (es) Nuevas composiciones inmunogénicas para la prevención y tratamiento de enfermedad meningocócica
KR100205462B1 (ko) 라임 질병에 대한 왁진
CA2040544C (en) Actinobacillus pleuropneumoniae subunit vaccine
CN105949287B (zh) 一种a型副鸡禽杆菌免疫保护性抗原及其应用
DK173361B1 (da) Isoleret proteinholdigt materiale, dræbte hele celler af Pasteurella hæmolytica, vaccine mod Pasteurella og fremgangsmåde t
JPH0592929A (ja) ヘモフイルスパラガリナルムワクチン
Shivachandra et al. Immunogenicity of recombinant Omp16 protein of Pasteurella multocida B: 2 in mouse model
US5593679A (en) Poultry vaccine against E. coli air sac inflammation and septicaemia
Guzmán-Brambila et al. LKTA and PlpE small fragments fusion protein protect against Mannheimia haemolytica challenge
MX2010010614A (es) Composiciones, metodos y kits.
WO2014146603A1 (zh) 败血性巴氏杆菌毒素重组蛋白及其应用
CA2516661C (en) M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever
WO2020203731A1 (ja) 肺炎球菌表層タンパク質
Rajeev et al. Bordetella bronchiseptica fimbrial protein-enhanced immunogenicity of a Mannheimia haemolytica leukotoxin fragment
Mao et al. Expression and immunogenicity analysis of two iron-regulated outer membrane proteins of Vibrio parahaemolyticus
WO2011018779A1 (en) Modified helicobacter protein
CN111511393A (zh) 一种针对胸膜肺炎放线杆菌保护猪的疫苗
RU2818278C2 (ru) Пневмококковые поверхностные белки
Alvarez et al. Identification of immunodominant proteins from Mannheimia haemolytica and Histophilus somni by an immunoproteomic approach
KR20140071131A (ko) 살모넬라 갈리나룸의 세포외막단백질을 포함하는 가금티푸스 예방용 백신 조성물
GONZALEZ BLS protein as BRV antigen delivery system in a suckling mice model
JP2019512504A (ja) アドヘシン先端マルチエピトープ融合抗原プラットフォーム及びワクチン、並びに腸管毒素原性下痢の治療におけるそれらの使用
IE20100505A1 (en) Modified helicobacter protein

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C15 Extension of patent right duration from 15 to 20 years for appl. with date before 31.12.1992 and still valid on 11.12.2001 (patent law change 1993)
OR01 Other related matters
ASS Succession or assignment of patent right

Owner name: INTERVET INTERNATIONAL CO., LTD.

Free format text: FORMER OWNER: AKZO NOVEL N.V. CORP.

Effective date: 20061222

C41 Transfer of patent application or patent right or utility model
C56 Change in the name or address of the patentee

Owner name: AKZO NOVEL N.V. CORP.

Free format text: FORMER NAME OR ADDRESS: AKZO N. V.

CP01 Change in the name or title of a patent holder

Address after: Holland Arne

Patentee after: AKZO NOBEL N.V.

Address before: Holland Arne

Patentee before: Akzo N

TR01 Transfer of patent right

Effective date of registration: 20061222

Address after: Holland Haier box

Patentee after: INTERVET INTERNATIONAL B.V.

Address before: Holland Arne

Patentee before: AKZO NOBEL N.V.

C17 Cessation of patent right
CX01 Expiry of patent term

Expiration termination date: 20100818

Granted publication date: 20010228